Identification of Potential Genes Related to Breast Cancer Brain Metastasis in Breast Cancer Patients

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2021 Sep 20

PMID 34541602

Citations 22

Authors

Lijian Zhang

Luxuan Wang

Hua Yang

Chunhui Li

Chuan Fang

Affiliations

Soon will be listed here.

Abstract

Brain metastases (BMs) usually develop in breast cancer (BC) patients. Thus, the molecular mechanisms of breast cancer brain metastasis (BCBM) are of great importance in designing therapeutic strategies to treat or prevent BCBM. The present study attempted to identify novel diagnostic and prognostic biomarkers of BCBM. Two datasets (GSE125989 and GSE100534) were obtained from the Gene Expression Omnibus (GEO) database to find differentially expressed genes (DEGs) in cases of BC with and without brain metastasis (BM). A total of 146 overlapping DEGs, including 103 up-regulated and 43 down-regulated genes, were identified. Functional enrichment analysis showed that these DEGs were mainly enriched for functions including extracellular matrix (ECM) organization and collagen catabolic fibril organization. Using protein-protein interaction (PPI) and principal component analysis (PCA) analysis, we identified ten key genes, including LAMA4, COL1A1, COL5A2, COL3A1, COL4A1, COL5A1, COL5A3, COL6A3, COL6A2, and COL6A1. Additionally, COL5A1, COL4A1, COL1A1, COL6A1, COL6A2, and COL6A3 were significantly associated with the overall survival of BC patients. Furthermore, COL6A3, COL5A1, and COL4A1 were potentially correlated with BCBM in human epidermal growth factor 2 (HER2) expression. Additionally, the miR-29 family might participate in the process of metastasis by modulating the cancer microenvironment. Based on datasets in the GEO database, several DEGs have been identified as playing potentially important roles in BCBM in BC patients.

Citing Articles

Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets.

Liu Z, Zhang X, Ben T, Li M, Jin Y, Wang T Biomark Res. 2025; 13(1):38.

PMID: 40045379 PMC: 11884212. DOI: 10.1186/s40364-025-00745-7.

Exploring the key genes associated with breast cancer radiotherapy sensitivity based on the stromal-immune score and analysis of the WGCNA and ceRNA network.

Sun X, Wu C, Lin Y, Zhang S, Zhao X, Wang X Heliyon. 2025; 10(14):e34630.

PMID: 39816347 PMC: 11734054. DOI: 10.1016/j.heliyon.2024.e34630.

Metastatic brain tumors: from development to cutting-edge treatment.

Tanzhu G, Chen L, Ning J, Xue W, Wang C, Xiao G MedComm (2020). 2024; 6(1):e70020.

PMID: 39712454 PMC: 11661909. DOI: 10.1002/mco2.70020.

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.

van Bree N, Oppelt A, Lindstrom S, Zhou L, Boutin L, Coyle B Neuro Oncol. 2024; 27(3):779-794.

PMID: 39383211 PMC: 11889719. DOI: 10.1093/neuonc/noae210.

Digital Whole Slide Image Analysis of Elevated Stromal Content and Extracellular Matrix Protein Expression Predicts Adverse Prognosis in Triple-Negative Breast Cancer.

Karancsi Z, Gregus B, Krenacs T, Cserni G, Nagy A, Szocs-Trinfa K Int J Mol Sci. 2024; 25(17).

PMID: 39273393 PMC: 11394775. DOI: 10.3390/ijms25179445.

References

Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H . Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol. 2007; 20(8):864-70. DOI: 10.1038/modpathol.3800830. View

Narita Y, Shibui S . Strategy of surgery and radiation therapy for brain metastases. Int J Clin Oncol. 2009; 14(4):275-80. DOI: 10.1007/s10147-009-0917-0. View

Wang Y, Zhang X, Li H, Yu J, Ren X . The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013; 92(3):123-8. DOI: 10.1016/j.ejcb.2012.11.004. View

Tan W, Zhang W, Strasner A, Grivennikov S, Cheng J, Hoffman R . Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature. 2011; 470(7335):548-53. PMC: 3166217. DOI: 10.1038/nature09707. View

Custodio-Santos T, Videira M, Brito M . Brain metastasization of breast cancer. Biochim Biophys Acta Rev Cancer. 2017; 1868(1):132-147. DOI: 10.1016/j.bbcan.2017.03.004. View

Beasley K, Toms S . The molecular pathobiology of metastasis to the brain: a review. Neurosurg Clin N Am. 2010; 22(1):7-14, v. DOI: 10.1016/j.nec.2010.08.009. View

Lowery F, Yu D . Brain metastasis: Unique challenges and open opportunities. Biochim Biophys Acta Rev Cancer. 2016; 1867(1):49-57. PMC: 5272787. DOI: 10.1016/j.bbcan.2016.12.001. View

Xu S, Xu H, Wang W, Li S, Li H, Li T . The role of collagen in cancer: from bench to bedside. J Transl Med. 2019; 17(1):309. PMC: 6744664. DOI: 10.1186/s12967-019-2058-1. View

Wang S, Chen P, Sung Y, Huang W, Huang H, Chu P . Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients. J Oncol. 2020; 2020:5209695. PMC: 7255048. DOI: 10.1155/2020/5209695. View

10.

Sayyad M, Puchalapalli M, Vergara N, Wangensteen S, Moore M, Mu L . Syndecan-1 facilitates breast cancer metastasis to the brain. Breast Cancer Res Treat. 2019; 178(1):35-49. DOI: 10.1007/s10549-019-05347-0. View

11.

Evans A, James J, Cornford E, Chan S, Burrell H, Pinder S . Brain metastases from breast cancer: identification of a high-risk group. Clin Oncol (R Coll Radiol). 2004; 16(5):345-9. DOI: 10.1016/j.clon.2004.03.012. View

12.

Chong X, Peng R, Sun Y, Zhang L, Zhang Z . Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis. Biomed Res Int. 2020; 2020:7658230. PMC: 7525308. DOI: 10.1155/2020/7658230. View

13.

Gebeshuber C, Zatloukal K, Martinez J . miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009; 10(4):400-5. PMC: 2672883. DOI: 10.1038/embor.2009.9. View

14.

Gao F, Liang B, Reddy S, Farias-Eisner R, Su X . Role of inflammation-associated microenvironment in tumorigenesis and metastasis. Curr Cancer Drug Targets. 2013; 14(1):30-45. DOI: 10.2174/15680096113136660107. View

15.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

16.

Soysal S, Tzankov A, Muenst S . Role of the Tumor Microenvironment in Breast Cancer. Pathobiology. 2015; 82(3-4):142-52. DOI: 10.1159/000430499. View

17.

Lopez J, Kang I, You W, McDonald D, Weaver V . In situ force mapping of mammary gland transformation. Integr Biol (Camb). 2011; 3(9):910-21. PMC: 3564969. DOI: 10.1039/c1ib00043h. View

18.

Morris B, Burkel B, Ponik S, Fan J, Condeelis J, Aguirre-Ghiso J . Collagen Matrix Density Drives the Metabolic Shift in Breast Cancer Cells. EBioMedicine. 2016; 13:146-156. PMC: 5264313. DOI: 10.1016/j.ebiom.2016.10.012. View

19.

Chen G, Chakravarti N, Aardalen K, Lazar A, Tetzlaff M, Wubbenhorst B . Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin Cancer Res. 2014; 20(21):5537-46. PMC: 4216765. DOI: 10.1158/1078-0432.CCR-13-3003. View

20.

Van Swearingen A, Siegel M, Anders C . Breast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition?. Breast Cancer Res. 2015; 16(3):304. PMC: 4052941. DOI: 10.1186/bcr3651. View